Publication: 4704

Alliance A071601: Phase II trial of BRAF/MEK inhibition in recurrent papillary craniopharyngiomas
Google Scholar   
Citation:
Meeting Instance:
SNO 2025
Year:
2025
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
Genentech  
Grants:
U10CA180821, U10CA180882; U10CA180868 (NRG Oncology);  
Corr. Author:
 
Authors:
                                         
Networks:
CA088, FL028, LAPS-IL036, LAPS-MA036, LAPS-MN026, LAPS-OH007, NC002   
Study
Alliance-A071601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: